In a murine BC model, the MUC-1 liposome vaccine and interleukin 2 (IL-2) were investigated; it could induce interferon gamma (IFN-γ) secreting T cell, which target MUC-1 [46]. The gene discussed is MUC1; the disease is breast cancer.